BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37558009)

  • 1. Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis.
    Monteiro Neto JR; Ribeiro GD; Magalhães RSS; Follmer C; Outeiro TF; Eleutherio ECA
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166835. PubMed ID: 37558009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicarbonate-dependent peroxidase activity of human Cu,Zn-superoxide dismutase induces covalent aggregation of protein: intermediacy of tryptophan-derived oxidation products.
    Zhang H; Andrekopoulos C; Joseph J; Chandran K; Karoui H; Crow JP; Kalyanaraman B
    J Biol Chem; 2003 Jun; 278(26):24078-89. PubMed ID: 12686560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
    Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
    Kerman A; Liu HN; Croul S; Bilbao J; Rogaeva E; Zinman L; Robertson J; Chakrabartty A
    Acta Neuropathol; 2010 Mar; 119(3):335-44. PubMed ID: 20111867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Hirano A; Kato S; Nagai R; Horiuchi S; Komori T; Umahara T; Asayama K; Kobayashi M
    Acta Neuropathol; 1999 Mar; 97(3):240-6. PubMed ID: 10090670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
    Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP
    J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein misdirection inside and outside motor neurons in Amyotrophic Lateral Sclerosis (ALS): a possible clue for therapeutic strategies.
    Ido A; Fukuyama H; Urushitani M
    Int J Mol Sci; 2011; 12(10):6980-7003. PubMed ID: 22072931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.
    Parakh S; Jagaraj CJ; Vidal M; Ragagnin AMG; Perri ER; Konopka A; Toth RP; Galper J; Blair IP; Thomas CJ; Walker AK; Yang S; Spencer DM; Atkin JD
    Hum Mol Genet; 2018 Apr; 27(8):1311-1331. PubMed ID: 29409023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation.
    Kato S; Nakashima K; Horiuchi S; Nagai R; Cleveland DW; Liu J; Hirano A; Takikawa M; Kato M; Nakano I; Sakoda S; Asayama K; Ohama E
    Neuropathology; 2001 Mar; 21(1):67-81. PubMed ID: 11304045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
    Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
    Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
    Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
    Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.